{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:34:04Z","timestamp":1782293644579,"version":"3.54.5"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug-induced hyperpigmentation (DIH) represents a significant subset of acquired pigmentation disorders and poses diagnostic challenges due to delayed onset and polypharmacy. This systematic review and meta-analysis aimed to identify medications significantly associated with DIH and evaluate their reported incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic search was conducted across PubMed, Scopus, Web of Science, and Cochrane Library for studies published between 2002 and June 2024. Eligible studies reported DIH as an outcome with incidence or descriptive data. Pooled proportions were calculated using a random-effects model, and heterogeneity was assessed via the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-two studies met the inclusion criteria. The overall pooled incidence of DIH was 36.7% (95% CI: 0.291\u20130.444). Subgroup analyses revealed the highest incidences with tyrosine kinase inhibitors (89.2%) and MC4R agonists (71.4%), followed by antibiotics (52.0%), antineoplastic agents (35.5%), and antimalarials (29.0%). Commonly implicated agents included minocycline, hydroxychloroquine, and hydroxyurea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DIH is a prevalent adverse drug reaction with considerable variation in incidence across drug classes. Recognition of high-risk medications is essential for prompt diagnosis and clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>The study protocol was pre-registered in the International Prospective Register of Systematic Reviews (PROSPERO: CRD42024529250).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1674278","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:41:07Z","timestamp":1775551267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug induced hyperpigmentation: systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ruaa","family":"Alharithy","sequence":"first","affiliation":[{"name":"Security Forces Hospital","place":["Riyadh, Saudi Arabia"]},{"name":"Collage of medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayan","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Bin Salamah","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Altamimi","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Alqntash","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Alsarhan","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Khosyfan","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad","family":"Alrowais","sequence":"additional","affiliation":[{"name":"College of Medicine, Princess Nourah Bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2165\/00128071-200102040-00006","article-title":"Drug-induced skin pigmentation","volume":"2","author":"Dereure","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/jocd.12686","article-title":"Quality of life in patients with acquired pigmentation: an observational study","volume":"17","author":"Yadav","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3122\/jabfm.2019.04.180212","article-title":"Drug-induced hyperpigmentation: review and case series","volume":"32","author":"Gim\u00e9nez Garc\u00eda","year":"2019","journal-title":"J American Board Family Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s10637-021-01182-7","article-title":"Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial","volume":"40","author":"Wang","year":"2022","journal-title":"Investig New Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/15569527.2010.521225","article-title":"Antimalarial cutaneous side effects: a study in 209 users","volume":"30","author":"Skare","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/rheumatology\/keae217","article-title":"Hydroxychloroquine-induced pigmentation in rheumatic diseases: prevalence, clinical features and influencing factors","volume":"64","author":"Yin","year":"2024","journal-title":"Rheumatology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1007\/s00784-019-02886-0","article-title":"Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review","volume":"23","author":"Oliveira","year":"2019","journal-title":"Clin Oral Investig"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/ced\/llae254","article-title":"Needle-free jet injector treatment with bleomycin is efficacious in patients with severe keloids: a randomized, double-blind, placebo-controlled trial","volume":"49","author":"Bekkers","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/opth.s29912","article-title":"Comparison of the latanoprost 0.005%\/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%\/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial","volume":"6","author":"Nakakura","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/112067210801800315","article-title":"A 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension","volume":"18","author":"Goldberg","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/cid\/civ027","article-title":"Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China","volume":"60","author":"Tang","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref14","first-page":"827","article-title":"Drug-induced photosensitivity-an update: culprit drugs, prevention and management","volume-title":"Drug Saf","author":"Blakely","year":"2019"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4103\/0378-6323.72459","article-title":"Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil","volume":"76","author":"Rao","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref16","first-page":"237","article-title":"Organizational commitment in the military: a discussion of theory and practice","volume-title":"Organizational commitment in the military","author":"Allen","year":"2018"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"Alm","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bcr-2013-009745","article-title":"Bleomycin-induced flagellate hyperpigmentation","volume":"2013","author":"Resende","year":"2013","journal-title":"BMJ Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e01551","DOI":"10.1213\/xaa.0000000000001551","article-title":"Intralesional bleomycin injection and skin hyperpigmentation: a case series of a single-center experience with a standardized skin-protective protocol","volume":"16","author":"Heninger","year":"2022","journal-title":"A A Pract"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1358\/dot.2010.46.6.1482107","article-title":"A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension","volume":"46","author":"Hommer","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/archophthalmol.2010.89","article-title":"Latisse-induced periocular skin hyperpigmentation","volume":"128","author":"Priluck","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/02713680701750625","article-title":"The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy","volume":"32","author":"Sharpe","year":"2007","journal-title":"Curr Eye Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3906\/sag-1405-23","article-title":"Periocular changes in topical bimatoprost and latanoprost use","volume":"45","author":"Karslio\u011flu","year":"2015","journal-title":"Turk J Med Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/sj.eye.6701663","article-title":"Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes","volume":"19","author":"Chou","year":"2004","journal-title":"Eye"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jaad.2017.06.044","article-title":"Pigmentary changes in patients treated with targeted anticancer agents: a systematic review and meta-analysis","volume":"77","author":"Dai","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5070\/D3472203P2","article-title":"Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST","volume":"14","author":"Alexandrescu","year":"2008","journal-title":"Dermatol Online J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13257","article-title":"Yellowish nail pigmentation caused by sunitinib","volume":"55","author":"Espinosa Lara","year":"2016","journal-title":"Int J Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3402\/jchimp.v4.24063","article-title":"Minocycline-induced hyperpigmentation","volume":"4","author":"Fiscus","year":"2014","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jaad.2007.04.028","article-title":"The histopathology of subcutaneous minocycline pigmentation","volume":"57","author":"Bowen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.11604\/pamj.2022.42.14.34956","article-title":"Clofazimine induced pigmentation in leprosy patches","volume":"42","author":"Chavhan","year":"2022","journal-title":"Pan Afr Med J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jid.2017.09.031","article-title":"The physicochemical basis of clofazimine-induced skin pigmentation","volume":"138","author":"Murashov","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"876695","DOI":"10.3389\/falgy.2022.876695","article-title":"Drug-induced photosensitivity: clinical types of phototoxicity and photoallergy and pathogenetic mechanisms","volume":"3","author":"Di Bartolomeo","year":"2022","journal-title":"Front Allergy"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/ph14080723","article-title":"Drug-induced photosensitivity\u2014from light and chemistry to biological reactions and clinical symptoms","volume":"14","author":"Kowalska","year":"2021","journal-title":"Pharmaceuticals"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/pharmaceutics12111104","article-title":"Latest evidence regarding the effects of photosensitive drugs on the skin: pathogenetic mechanisms and clinical manifestations","volume":"12","author":"Lozzi","year":"2020","journal-title":"Pharmaceutics"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2020.04.024","article-title":"Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review","volume":"83","author":"Sharma","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijwd.2020.06.009","article-title":"A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature","volume":"6","author":"Kwak","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/03009740701769735","article-title":"Hyperpigmentation of the skin due to hydroxychloroquine","volume":"37","author":"Rood","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/jocd.12440","article-title":"Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo","volume":"17","author":"Mina","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/bjo.86.10.1085","article-title":"Incidence of iris colour change in latanoprost treated eyes","volume":"86","author":"Teus","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1634\/theoncologist.2018-0901","article-title":"S-1 plus Raltitrexed for refractory metastatic colorectal Cancer: a phase II trial","volume":"24","author":"Chen","year":"2019","journal-title":"Oncologist"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/bcpt.13238","article-title":"Real-world safety evaluation of topical corticosteroid use: a community pharmacy-based, prospective, observational study","volume":"125","author":"Ah","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10147-020-01646-5","article-title":"Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival","volume":"25","author":"Ando","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/JCAS.JCAS_153_20","article-title":"Efficacy of fractional carbon dioxide laser (FCO 2) with intralesional 5-fluorouracil (5-FU) in the treatment of keloids","volume":"14","author":"Alhamzawi","year":"2021","journal-title":"J Cutan Aesthet Surg"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/IJG.0b013e3181e08121","article-title":"Five-year, multicenter safety study of fixed-combination latanoprost\/timolol (Xalacom) for open-angle glaucoma and ocular hypertension","volume":"20","author":"Alm","year":"2011","journal-title":"J Glaucoma"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamadermatol.2013.1989","article-title":"Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection","volume":"149","author":"Tsilika","year":"2013","journal-title":"JAMA Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1111\/jocd.14388","article-title":"The clinical and pathological effectiveness of microneedling and topical 5-fluorouracil in vitiligo treatment: an association with matrix metalloproteinase 2 immunohistochemical expression","volume":"21","author":"Abdou","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/ijd.ijd_1056_23","article-title":"Microneedling and 5-fluorouracil in treating stable vitiligo in hitherto unstudied high prevalence population","volume":"69","author":"Abhirami","year":"2024","journal-title":"Indian J Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofv107","article-title":"Minocycline-induced cutaneous hyperpigmentation in an orthopedic patient population","volume":"3","author":"Hanada","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/2000656X.2014.951051","article-title":"Intralesional bleomycin injection in management of low flow vascular malformations in children","volume":"49","author":"Mohan","year":"2015","journal-title":"J Plast Surg Hand Surg"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/ddg.12042","article-title":"Drug-induced hyperpigmentation: A systematic review","volume":"11","author":"Krause","year":"2013","journal-title":"Journal der Deutschen Dermatologischen Gesellschaf"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1674278\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:41:08Z","timestamp":1775551268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1674278\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":51,"alternative-id":["10.3389\/fmed.2026.1674278"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1674278","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"article-number":"1674278"}}